Harvey ES, Hamada Y, Hiles SA, Langton D, et al. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
PMID: 40912662